Not found

Edward A. Graviss, PhD, MPH

Associate Professor of Pathology and Genomic Medicine, Institute for Academic Medicine
Associate Member, Research Institute
Houston Methodist


Research Lab


eagraviss@houstonmethodist.org
Biography

After receiving his doctoral degree in Epidemiology from The University of Texas Health Science Center at Houston, School of Public Health in 1993, Dr. Graviss joined the Michael DeBakey Houston VA Medical Center in Houston as an infectious disease epidemiologist, a position he still holds. He became a Research Instructor of Medicine at Baylor College of Medicine in 1994, and was later promoted to dual Associate Professorships there in the Departments of Pathology and Medicine in the section of Infectious Diseases, where he still holds adjunct positions. Dr. Graviss joined the Center for Molecular and Translational Human Infectious Diseases Research in the Houston Methodist Research Institute in 2008. Dr. Graviss holds several other joint adjunct positions including; Associate Professorships at the UT School of Public Health and the Division of the Health Sciences, the School of Biotechnology, and Health Tecnolóico de Monterrey, Monterrey, Mexico.

 

Description of Research

Dr. Graviss has extensive expertise in the study of the epidemiology and population-based surveillance of a variety of infectious agents including Mycobacterium tuberculosis. His recent studies focus on evaluation of the new Interferon Gamma Release Assays (IGRAs) in the diagnosis of latent tuberculosis infection.

Areas Of Expertise

Infectious agents Mycobacterium tuberculosis Latent tuberculosis
Education & Training

PhD , University of Texas Health Science Center
MPH , The University of Texas Health Science Center
MS , University of Texas San Antonio
BS , Texas Tech. University
Publications

Evaluation of 24-locus MIRU-VNTR genotyping in Mycobacterium tuberculosis cluster investigations in four jurisdictions in the United States, 2006–2010
Teeter, LD, Kammerer, JS, Ghosh, S, Nguyen, DTM, Vempaty, P, Tapia, J, Miramontes, R, Cronin, WA, Graviss, EA & Tuberculosis Epidemiologic Studies Consortium 2017, Tuberculosis, vol 106, pp. 9-15. DOI:

Evaluation of 24-locus MIRU-VNTR genotyping in Mycobacterium tuberculosis cluster investigations in four jurisdictions in the United States, 2006–2010
Teeter, LD, Kammerer, JS, Ghosh, S, Nguyen, DTM, Vempaty, P, Tapia, J, Miramontes, R, Cronin, WA, Graviss, EA & Tuberculosis Epidemiologic Studies Consortium 2017, Tuberculosis, vol 106, pp. 9-15. DOI:

Evaluation of 24-locus MIRU-VNTR genotyping in Mycobacterium tuberculosis cluster investigations in four jurisdictions in the United States, 2006–2010
Teeter, LD, Kammerer, JS, Ghosh, S, Nguyen, DTM, Vempaty, P, Tapia, J, Miramontes, R, Cronin, WA, Graviss, EA & Tuberculosis Epidemiologic Studies Consortium 2017, Tuberculosis, vol 106, pp. 9-15. DOI:

Evaluation of 24-locus MIRU-VNTR genotyping in Mycobacterium tuberculosis cluster investigations in four jurisdictions in the United States, 2006–2010
Teeter, LD, Kammerer, JS, Ghosh, S, Nguyen, DTM, Vempaty, P, Tapia, J, Miramontes, R, Cronin, WA, Graviss, EA & Tuberculosis Epidemiologic Studies Consortium 2017, Tuberculosis, vol 106, pp. 9-15. DOI:

Clinical & bacteriological characteristics associated with clustering of multidrug-resistant tuberculosis
Feng, JY, Jarlsberg, LG, Salcedo, K, Rose, J, Janes, M, Lin, SYG, Osmond, DH, Jost, KC, Soehnlen, MK, Flood, J, Graviss, EA, Desmond, E, Moonan, PK, Nahid, P, Hopewell, PC & Kato-Maeda, M 2017, International Journal of Tuberculosis and Lung Disease, vol 21, no. 7, pp. 766-773. DOI:

Early clearance vs persistence of de novo donor-specific antibodies following lung transplantation
Islam, AK, Sinha, N, DeVos, JM, Kaleekal, TS, Jyothula, SS, Teeter, LD, Nguyen, DTM, Eagar, TN, Moore, LW, Puppala, M, Wong, STC, Knight, RJ, Frost, AE, Graviss, EA & Osama Gaber, A 2017, Clinical Transplantation. DOI:

Incidence and Factors Associated with De Novo DSA After BK Viremia in Renal Transplant Recipients
Patel, SJ, Kuten, SA, Knight, RJ, Graviss, EA, Nguyen, DTM & Gaber, AO 2017, . in Clinical Transplants 2016. Terasaki Research Institute, Los Angeles, California, pp. 103-109.

Spatial-temporal distribution of genotyped tuberculosis cases in a county with active transmission
Agarwal, S, Nguyen, DT, Teeter, LD & Graviss, EA 2017, BMC Infectious Diseases, vol 17, no. 1, 378. DOI:

Spatial-temporal distribution of genotyped tuberculosis cases in a county with active transmission
Agarwal, S, Nguyen, DT, Teeter, LD & Graviss, EA 2017, BMC Infectious Diseases, vol 17, no. 1, 378. DOI:

Spatial-temporal distribution of genotyped tuberculosis cases in a county with active transmission
Agarwal, S, Nguyen, DT, Teeter, LD & Graviss, EA 2017, BMC Infectious Diseases, vol 17, no. 1, 378. DOI:

Spatial-temporal distribution of genotyped tuberculosis cases in a county with active transmission
Agarwal, S, Nguyen, DT, Teeter, LD & Graviss, EA 2017, BMC Infectious Diseases, vol 17, no. 1, 378. DOI:

Clinical and bacteriological characteristics associated with clustering of multidrug-resistant tuberculosis
J-Y Feng, J-Y, Jarlsberg, LG, Salcedo, K, Rose, J, Janes, M, Lin, S-YG, Osmond, DH, Jost, KC, Soehnlen, MK, Flood, J, Graviss, EA, Desmond, E, Moonan, PK, Nahid, P, Hopewell, PC & Kato-Maeda, M 2017, International Journal of Tuberculosis and Lung Disease, vol 5. DOI:

Quantification of circulating Mycobacterium tuberculosis antigen peptides allows rapid diagnosis of active disease and treatment monitoring
Liu, YC, Zhao, Z, Fan, J, Lyon, CJ, Wu, HJ, Nedelkov, D, Zelazny, AM, Olivier, KN, Cazares, LH, Holland, SM, Graviss, EA & Hu, TY 2017, Proceedings of the National Academy of Sciences of the United States of America, vol 114, no. 15, pp. 3969-3974. DOI:

Outcomes and costs of out-patient MDR-TB care in the USA
Marks, SM, Hirsch-Moverman, Y, Seaworth, B, Salcedo, K, Graviss, EA, Armstrong, L, Armitige, L, Flood, J & Mase, S 2017, International Journal of Tuberculosis and Lung Disease, vol 21, no. 4, pp. 477-478. DOI:

Longitudinal change in pulmonary arterial capacitance as an indicator of prognosis and response to therapy and in pulmonary arterial hypertension
Medrek, SK, Kloefkorn, C, Nguyen, DTM, Graviss, EA, Frost, AE & Safdar, Z 2017, Pulmonary circulation, vol 7, no. 1. DOI:

Evaluation of Xpert MTB/RIF in detection of pulmonary and extrapulmonary tuberculosis cases in China
Jing, H, Lu, Z, Deng, Y, Gao, D, Li, L, Graviss, EA & Ma, X 2017, International Journal of Clinical and Experimental Pathology, vol 10, no. 4, pp. 4847-4851.

In-hospital use of non-steroidal anti-inflammatory drugs in patients with heart failure in academic centers in the United States
Alvarez, PA, Nguyen, DT, Schutt, R, Ganduglia, C, Estep, JD, Graviss, EA & Putney, D 2017, International Journal of Risk and Safety in Medicine, vol 28, no. 4, pp. 181-188. DOI:

Longitudinal change in pulmonary arterial capacitance as an indicator of prognosis and response to therapy and in pulmonary arterial hypertension
Medrek, SK, Kloefkorn, C, Nguyen, DTM, Graviss, EA, Frost, AE & Safdar, Z 2017, Pulmonary Circulation, vol 7, no. 2, pp. 399-408. DOI:

Predictive value of serum bradykinin and desArg9-bradykinin levels for chemotherapeutic responses in active tuberculosis patients: A retrospective case series
Qian, X, Nguyen, DTM, Li, Y, Lyu, J, Graviss, E & Hu, TY 2016, Tuberculosis, vol 101, pp. S109-S118. DOI:

Texas Tuberculosis Research Symposium 2016: Research and clinical collaboration within the state of Texas towards elimination of TB
Graviss, EA & Actor, JK 2016, Tuberculosis, vol 101, pp. S1. DOI: